Feasibility and Safety of Endoscopic Control for Patients with Serrated Polyposis Syndrome
Digestive Diseases · 2024
DOI: 10.1159/000534968 ↗Kurz gefasst
Fachartikel in der Zeitschrift Digestive Diseases, 2024. Verfasst von Michiko Nakaoka und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Omori Red Cross Hospital, Tokyo, Japan, michiko_cinnamon@ybb.ne.jp. Hauptthemen laut MEDLINE: Colonic Polyps, Adenomatous Polyposis Coli, Colorectal Neoplasms. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Despite advances in endoscopic treatment, patients with serrated polyposis syndrome (SPS) occasionally require surgery due to numerous or unresectable polyps, recurrence, and treatment-related adverse events.
Methods
We retrospectively evaluated 43 patients with SPS undergoing diagnosis and treatment at Omori Red Cross Hospital from 2011 to 2022. Resection of all polyps ≥3 mm in size was planned during the clearing phase; endoscopic control was defined as complete, endoscopic polyp removal. During the surveillance phase, patients underwent annual colonoscopy and resection of newly detected polyps ≥3 mm in size.
Results
Thirty-eight patients (88%) achieved endoscopic control, two (5%) required surgery after endoscopic treatment because of colorectal cancer (CRC), and three (7%) have not yet achieved endoscopic control and are planning treatment. Endoscopic control was achieved with a median of four colonoscopies at 8 months. Ten polyps (median value) were resected per patient during the clearing phase. Three polyps ≥50 mm in size, six located in the appendiceal orifice, and seven with severe fibrosis could be resected by endoscopic submucosal dissection (ESD). All patients underwent treatment with a combination of cold snare polypectomy (CSP), endoscopic mucosal resection/hot polypectomy, and/or ESD. No case required surgery due to difficulty with endoscopic treatment. Delayed bleeding was observed in 2 cases (0.3%). Twenty-one patients underwent colonoscopies during the surveillance phase. Fifty-three polyps were resected using CSP; no CRC, sessile serrated lesions with dysplasia, or advanced adenoma were detected.
Conclusion
SPS can be effectively, efficiently, and safely controlled with appropriate endoscopic management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Omori Red Cross Hospital, Tokyo, Japan, michiko_cinnamon@ybb.ne.jp.
- Department of Gastroenterology, Omori Red Cross Hospital, Tokyo, Japan.
- Department of Gastroenterology, Yokohama Rosai Hospital, Yokohama, Japan.
- Department of Gastroenterology, Hiratsuka City Hospital, Hiratsuka, Japan.
- Ashikari Medical Clinic, Tokyo, Japan.
Zitieren
APA
Nakaoka, M., Chiba, H., Kobayashi, M., Okada, N., Arimoto, J., Tachikawa, J., Ashikari, K., & Kuwabara, H. (2024). Feasibility and Safety of Endoscopic Control for Patients with Serrated Polyposis Syndrome. Digestive Diseases. https://doi.org/10.1159/000534968
Vancouver
Nakaoka M, Chiba H, Kobayashi M, Okada N, Arimoto J, Tachikawa J, et al. Feasibility and Safety of Endoscopic Control for Patients with Serrated Polyposis Syndrome. Digestive Diseases. 2024. doi:10.1159/000534968
BibTeX
@article{Nakaoka2024,
author = {Nakaoka, Michiko and Chiba, Hideyuki and Kobayashi, Mikio and Okada, Naoya and Arimoto, Jun and Tachikawa, Jun and Ashikari, Keiichi and Kuwabara, Hiroki},
title = {Feasibility and Safety of Endoscopic Control for Patients with Serrated Polyposis Syndrome},
journal = {Digestive Diseases},
year = {2024},
doi = {10.1159/000534968}
}
EUVIMED